Request a document copy: ‘In silico’ design and validation of novel cyclin dependent kinase (CDK) receptor inhibitors, using the palbociclib scaffold, a molecule for the management for breast cancer as a lead

all files (of this document) in restricted access
the file(s) you requested
Cancel